Physician profile
Ossama Elsaid
NPI 1467799353
$34,008.30
in general payments reported to CMS, 2019-2025
18 companies · $33K in 2025
The $33K reported for 2025 was more than what 95% of Interventional Cardiology providers received nationally (typical 2025 total: $1,092).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $76.32 · 2021: $449 · 2022: $68.07 · 2023: $223 · 2024: $587 · 2025: $33K.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Grant: $29K · Food and Beverage: $2,686 · Travel and Lodging: $2,228 · Education: $1.00.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Grant | $28,500.00 |
| Food and Beverage | $2,686.43 |
| Travel and Lodging | $2,227.94 |
| Education | $1.00 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Medtronic, INC. | $16,172.65 | 2023-2025 | Corevalve Evolut R, Onyx Frontier, Euphora |
| Abbott Laboratories | $13,607.14 | 2019-2025 | Mitraclip, Xience Skypoint, Aveir |
| Edwards Lifesciences Corporation | $2,515.66 | 2022-2025 | Sapien 3 Ultra Resilia |
| Boston Scientific Corporation | $561.18 | 2019-2025 | Synergy, Avvigo Guidance System, Guidezilla |
| Abiomed | $408.88 | 2021-2025 | Impella |
| Penumbra, INC. | $174.78 | 2024-2025 | Indigo System |
| Chiesi USA, INC. | $132.02 | 2021 | |
| Cardiovascular Systems INC. | $124.34 | 2021 | |
| Inari Medical, INC. | $71.23 | 2021 | |
| Pfizer INC. | $43.59 | 2021 | |
| Biosense Webster, INC. | $35.75 | 2019 | |
| Shockwave Medical, INC | $35.04 | 2024 | Shockwave Ivl System With The Shockwave C2 Coronary Ivl Catheter |
| Astrazeneca Pharmaceuticals LP | $27.97 | 2024 | |
| Philips North America LLC | $24.83 | 2022 | |
| Zoll Services LLC (A/K/A Zoll Lifecor Corp) | $23.96 | 2024 | Lifevest |
Show all 18 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Boehringer Ingelheim Pharmaceuticals, INC. | $16.92 | 2023 | Jardiance |
| Novartis Pharmaceuticals Corporation | $16.58 | 2024 | |
| Vital Connect, INC | $15.78 | 2025 | Vitalpatch Rtm |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Ossama Elsaid listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.